Chemoinformaics analysis of Benzo(c)(2,7)naphthyridin-4(3H)-one
Molecular Weight | 196.209 | nRot | 0 |
Heavy Atom Molecular Weight | 188.145 | nRig | 17 |
Exact Molecular Weight | 196.064 | nRing | 3 |
Solubility: LogS | -3.541 | nHRing | 2 |
Solubility: LogP | 1.855 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 14 |
No. of Oxygen atom | 1 | No. of Arom Bond | 16 |
nHA | 2 | APOL | 28.3763 |
nHD | 1 | BPOL | 10.6037 |
QED | 0.559 |
Synth | 2.114 |
Natural Product Likeliness | -0.392 |
NR-PPAR-gamma | 0.015 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.004 |
Pgp-sub | 0.007 |
HIA | 0.067 |
CACO-2 | -4.597 |
MDCK | 0.0000191 |
BBB | 0.569 |
PPB | 0.683215 |
VDSS | 1.043 |
FU | 0.187262 |
CYP1A2-inh | 0.976 |
CYP1A2-sub | 0.516 |
CYP2c19-inh | 0.336 |
CYP2c19-sub | 0.171 |
CYP2c9-inh | 0.065 |
CYP2c9-sub | 0.765 |
CYP2d6-inh | 0.141 |
CYP2d6-sub | 0.772 |
CYP3a4-inh | 0.098 |
CYP3a4-sub | 0.108 |
CL | 5.665 |
T12 | 0.6 |
hERG | 0.089 |
Ames | 0.724 |
ROA | 0.933 |
SkinSen | 0.545 |
Carcinogencity | 0.543 |
EI | 0.941 |
Respiratory | 0.979 |
NR-Aromatase | 0.855 |
Antiviral | No |
Prediction | 0.599578 |